Celia Dominguez

Affiliation:CHDI Foundation

Link to group website: Website


Dr. Celia Dominguez is currently Vice President of Chemistry & Drug Discovery at CHDI Foundation a privately-funded, not-for-profit biomedical research organization devoted to a single disease – Huntington’s disease. CHDI’s mission is to develop drugs that will slow the progression of Huntington’s disease and provide meaningful clinical benefit to patients as quickly as possible.  Dr. Dominguez received a B.S. in Chemistry from the Rutgers University, her Ph.D. in Synthetic Organic Chemistry from Brown University, and Post-doctoral training at NIH/NIDDK.  Dr. Dominguez has over 30 years of drug discovery and development experience in the Pharmaceutical Biotechnology sector with Amgen and DuPont Merck, where she held positions of increasing responsibility and has had a consistent and impressive track record of publishing, patenting, and (most importantly) delivering therapeutic candidates for pre-clinical, clinical evaluation (7 clinical candidates) and one approved drug.

Currently, at CHDI Foundation she oversees all the Chemistry and Drug Discovery efforts at CHDI collaborating with Huntington’s Lowering, Genotype and Phenotype biology teams, and Clinical team to identify Proof of Concept molecules and therapeutic candidates.

Dr. Dominguez was born in Cuba, grew up in Elizabeth, New Jersey and currently resides in Los Angeles with her spouse and two English Bulldogs. She enjoys playing competitive USTA tennis, international travel, and fine wine.